Linde Meyaard

Utrecht University — Netherlands

Immunology and Microbiology · Life Sciences

53h-index9.4kcitations168works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(83), Immune Response and Inflammation(33), T-cell and B-cell Immunology(30), HIV Research and Treatment(23), Cell Adhesion Molecules Research(20)

Publications168 total

Targeting Inhibitory Immune Receptors in Inflammatory Disease, Guided by Molecular Understanding of Their Function
Annual Review of Immunology·2026
The scavenger receptor MARCO is a ligand for the immune inhibitory receptor LAIR-1 and regulates its function in cis
Science Signaling·2025
Meet the Brightest in Immunology: Q&A With Award‐Winning Researchers From the 2023 BIS‐NVVI Annual Meeting
European Journal of Immunology·2025Open Access
Inhibitory pattern recognition receptors: lessons from LAIR1
Nature reviews. Immunology·2025· 5 cited
Mesenchymal stem cells differentially suppress engineered T cell efficacy through collagen expression
Cytotherapy·2025
VSTM1/SIRL‐1: An Inhibitory Pattern Recognition Receptor Regulating Myeloid Cells
European Journal of Immunology·2025· 1 citedOpen Access
Author response for "VSTM1/SIRL‐1: An Inhibitory Pattern Recognition Receptor Regulating Myeloid Cells"
2025
Author response for "VSTM1/SIRL‐1: An Inhibitory Pattern Recognition Receptor Regulating Myeloid Cells"
2024
Author response: A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
eLife·2024· 9 citedOpen Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
Author response: A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients
Cancer Immunology Immunotherapy·2024· 1 citedOpen Access
Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis
Journal of Autoimmunity·2024· 3 citedOpen Access
Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy
Journal of Translational Medicine·2024· 32 citedOpen Access
Mechanosensing regulates tissue repair program in macrophages
Science Advances·2024· 64 citedOpen Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
2024Open Access
A novel bioinformatics pipeline for the identification of immune inhibitory receptors as potential therapeutic targets
eLife·2024· 4 citedOpen Access
Angiogenic factors and the lectin pathway of complement in women with secondary recurrent pregnancy loss
Journal of Reproductive Immunology·2024· 7 citedOpen Access
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice
Cancer Immunology Immunotherapy·2024· 8 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Talitha de Ruiter(12), Frank Miedema(7), Robert Jan Lebbink(6), Tomasz P. Rygiel(5), Maarten van der Linden(4), Frank Miedema(4), Frank E. J. Coenjaerts(3), Louis Bont(3), Hans Clevers(3), Sigrid A. Otto(3), Richard W. Farndale(3), Michiel van der Vlist(3), S A Otto(3), Hanneke Schuitemaker(3), Joël A. G. van Roon(3), René A. W. van Lier(3), Eva S. K. Rijkers(3), Robert M. Hoek(3), Geertje H. A. Westerlaken(3), Annelies Verbrugge(3)